WVE Stock Analysis: Buy, Sell, or Hold?

WVE - Wave Life Sciences Ltd. Ordinary Shares

PHARMACEUTICAL PREPARATIONS
$12.94
-0.07 (-0.54%) ▼
BUY
HIGH Confidence
Last Updated: January 30, 2026
Earnings: Mar 03, 2026 30d
Smart Money Accumulation

WVE is down 3.9% this week, but smart money is accumulating calls. Top strike: $10 2026-04-17 with 1,641 OI. Call ratio: 94% View Scanner →

Strength: 6.4/10

Get Alerted When WVE Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
✅ BUY SIGNAL: WVE shows strong fundamentals and good volume confirmation. Solid entry point despite oversold pricing.

In-depth Analysis How we analyze

Valuation Analysis: WVE is currently trading at $12.94, which is considered oversold relative to its 30-day fair value range of $13.23 to $16.73.

Technical Outlook: Technically, WVE is in a strong uptrend. Immediate support is located at $12.55, while resistance sits at $14.51.

Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $32.40 (+149.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.

Quick Decision Summary

Current Position OVERSOLD
Fair Price Range $13.23 - $16.73
Company Quality Score 54/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 82.6%

All Signals

  • BULLISH: Price oversold vs 30-day range
  • NEUTRAL: Mixed technical signals (40/100)
  • BULLISH: High volume confirmation
  • BULLISH: Trading 149.0% below Wall St target ($32.40)

Fair Price Analysis

30-Day Fair Range $13.23 - $16.73
Current vs Fair Value OVERSOLD

Support & Resistance Levels

Support Level $12.55
Resistance Level $14.51
Current Trend Strong Uptrend

Fundamental Context

Forward P/E (Next Year Est.) -10.94
Wall Street Target $32.40 (+149.0%)
Revenue Growth (YoY) -55.8%
Profit Margin -111.6%
Last updated: January 31, 2026 3:57 AM ET
Data refreshes hourly during market hours. Next update: 4:57 AM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Insider Activity (6 Months)
0
Buys
4
Sells
Net
INSIDERS SELLING
Recent Transactions
Gregory L Verdine SELL 10000 shares 2025-08-22
Paul Bolno SELL 217351 shares 2025-08-22
Christian O Henry SELL 9670 shares 2025-08-13

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
ONC
BeiGene, Ltd.
STRONG BUY
24 analysts
$404 63 BUY
RARE
Ultragenyx
STRONG BUY
20 analysts
$64 55 HOLD
RCKT
Rocket Pharmaceuticals I…
STRONG BUY
18 analysts
$8 53 HOLD
INCY
Incyte Corporation
HOLD
27 analysts
$102 62 BUY
CRNX
Crinetics Pharmaceutical…
STRONG BUY
17 analysts
$85 55 HOLD

Advanced WVE Option Strategies

Professional options setups generated by AI based on today's WVE price and gamma walls.

Iron Condor Bull Call Bear Put Collar

More Analysis for WVE

WVE Technical Chart WVE Price Prediction WVE Earnings Date WVE Investment Advisor WVE Fair Price Analyzer WVE Options Advisor WVE Options Chain WVE Options Analysis WVE Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals